Add Company
Join Now

Kojin Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kojin Therapeutics's estimated annual revenue is currently $4M per year.(i)
  • Kojin Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Kojin Therapeutics has 26 Employees.(i)
  • Kojin Therapeutics grew their employee count by -19% last year.

Kojin Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Associate DirectorReveal Email/Phone
3
Director, Corporate Development & OperationsReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Research Associate IIReveal Email/Phone
6
Executive AssistantReveal Email/Phone
7
Principal Scientist, Computational BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Kojin Therapeutics?

We translate our deep biological insight into cell states to small-molecule therapeutics. Our approach provides novel ways of treating cancer, fibrosis, ischemia and immune modulation. Kojin Therapeutics is founded by Benjamin Cravatt, Stephanie Dougan, Stuart Schreiber and Vasanthi Viswanathan.

keywords:N/A

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M260%$122.8M
#2
$2.6M26N/AN/A
#3
$2.6M26N/AN/A
#4
$2.6M26N/AN/A
#5
$2.6M26N/AN/A